ReviewTherapeutic advances in neurological disorders2017

Daclizumab high-yield process in the treatment of relapsing-remitting multiple sclerosis.

Jana Lizrova Preiningerova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.